clinical study conducted by ResearchAyu, demonstrating a significant milestone in the treatment of Rheumatoid Arthritis (RA) and ANA-positive autoimmune disorders. The data shows that with our proprietary Ayurvedic medicines, 80.64% of ANA-positive patients and 81.25% of RA factor–positive patients turned negative after treatment — a statistically significant improvement (p < 0.001). These results highlight ResearchAyu’s breakthrough in bringing autoimmune markers like RA Factor and ANA back to normal levels, setting a new benchmark in Ayurvedic treatment for conditions once considered incurable.
